125 related articles for article (PubMed ID: 2248211)
21. Heart Failure Impairs Muscle Blood Flow and Endurance Exercise Tolerance in COPD.
Oliveira MF; Arbex FF; Alencar MC; Souza A; Sperandio PA; Medeiros WM; Mazzuco A; Borghi-Silva A; Medina LA; Santos R; Hirai DM; Mancuso F; Almeida D; O'Donnell DE; Neder JA
COPD; 2016 Aug; 13(4):407-15. PubMed ID: 26790095
[TBL] [Abstract][Full Text] [Related]
22. Peripheral adaptations in congestive heart failure: a review.
Just H
Am J Med; 1991 May; 90(5B):23S-26S. PubMed ID: 2048569
[TBL] [Abstract][Full Text] [Related]
23. Direct and indirect assessment of skeletal muscle blood flow in chronic congestive heart failure.
LeJemtel TH; Scortichini D; Katz S
Am J Cardiol; 1988 Sep; 62(8):36E-39E. PubMed ID: 3046291
[TBL] [Abstract][Full Text] [Related]
24. [Therapy of heart failure with vasodilator agents].
Just H; Drexler H; Holubarsch C
Z Kardiol; 1988; 77 Suppl 5():97-101. PubMed ID: 3066044
[TBL] [Abstract][Full Text] [Related]
25. Relaxin, a pleiotropic vasodilator for the treatment of heart failure.
Teichman SL; Unemori E; Dschietzig T; Conrad K; Voors AA; Teerlink JR; Felker GM; Metra M; Cotter G
Heart Fail Rev; 2009 Dec; 14(4):321-9. PubMed ID: 19101795
[TBL] [Abstract][Full Text] [Related]
26. Peripheral abnormalities in chronic heart failure.
Adamopoulos S; Coats AJ
Postgrad Med J; 1991; 67 Suppl 1():S74-9; discussion S79-80. PubMed ID: 1924083
[TBL] [Abstract][Full Text] [Related]
27. Regional blood flow in chronic heart failure: the reason for the lack of correlation between patients' exercise tolerance and cardiac output?
Muller AF; Batin P; Evans S; Hawkins M; Cowley AJ
Br Heart J; 1992 Jun; 67(6):478-81. PubMed ID: 1622698
[TBL] [Abstract][Full Text] [Related]
28. Effect of angiotensin-converting enzyme inhibitors on the peripheral circulation in heart failure.
Drexler H
Am J Cardiol; 1992 Oct; 70(10):50C-54C. PubMed ID: 1414895
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms and how to treat heart failure.
Sonnenblick EH; Burkart F; Julian GD; Just H; Kubler W; Rutishauser W
Am J Med; 1989 Dec; 87(6B):96S-98S. PubMed ID: 2603889
[No Abstract] [Full Text] [Related]
30. Systemic and regional hemodynamic effects of isomazole in awake dogs with congestive heart failure.
Imai N; Liang CS; Stone CK; Hayes JS; Hood WB
J Pharmacol Exp Ther; 1987 Apr; 241(1):20-6. PubMed ID: 3572783
[TBL] [Abstract][Full Text] [Related]
31. Are alterations of skeletal muscle ultrastructure in patients with heart failure reversible under treatment with ACE-inhibitors?
Münzel T; Kurz S; Drexler H
Herz; 1993 Dec; 18 Suppl 1():400-5. PubMed ID: 8125419
[TBL] [Abstract][Full Text] [Related]
32. [Regional perfusion in heart failure. Changed distribution of blood flow caused by vasodilators].
Drexler H
Fortschr Med; 1987 Aug; 105(24):464-6. PubMed ID: 3653831
[No Abstract] [Full Text] [Related]
33. Endothelial control of lower limb blood flow in chronic heart failure.
Lindsay DC; Holdright DR; Clarke D; Anand IS; Poole-Wilson PA; Collins P
Heart; 1996 May; 75(5):469-76. PubMed ID: 8665339
[TBL] [Abstract][Full Text] [Related]
34. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH
Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945
[TBL] [Abstract][Full Text] [Related]
35. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
Drexler H; Faude F; Winterer H; Wollschläger H; Freudenberg N; Just H
Z Kardiol; 1987 Aug; 76(8):507-13. PubMed ID: 3314215
[TBL] [Abstract][Full Text] [Related]
36. Effect of hydralazine on perfusion and metabolism in the leg during upright bicycle exercise in patients with heart failure.
Wilson JR; Martin JL; Ferraro N; Weber KT
Circulation; 1983 Aug; 68(2):425-32. PubMed ID: 6861318
[TBL] [Abstract][Full Text] [Related]
37. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
Olivari MT; Levine TB; Cohn JN
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
[TBL] [Abstract][Full Text] [Related]
38. Selection of vasodilator, inotropic or combined therapy for the management of heart failure.
Cohn JN; Franciosa JA
Am J Med; 1978 Jul; 65(1):181-8. PubMed ID: 685992
[TBL] [Abstract][Full Text] [Related]
39. Future directions in vasodilator therapy for heart failure.
Cohn JN
Am Heart J; 1991 Mar; 121(3 Pt 1):969-74. PubMed ID: 2000775
[TBL] [Abstract][Full Text] [Related]
40. Regional blood flow in human congestive heart failure.
Leier CV
Am Heart J; 1992 Sep; 124(3):726-38. PubMed ID: 1514501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
